All roads seem to be leading to India as far as COVID-19 vaccine production is concerned. Soon after the Quad Alliance chose Biological E Limited. as a partner, the Russian Direct Investment Fund (RDIF) announced a tie-up with Gland Pharma Ltd. and Strides Pharma Science Limited unit Stelis Biopharma for the manufacture of Sputnik V.
Will Serum Institute Join Strides, Gland On The Sputnik V Flight?
Around 550 Million Doses Tied Up So Far
While speculation mounts about Serum Institute being next in line for an RDIF partnership, Gland Pharma and Strides unit Stelis sign up to make COVID-19 vaccine Sputnik V. Part of the 550 million dose output tied up from India so far could be consumed domestically, but exports are a possibility as demand from European countries is set to jump.
